High Potential for both Revenues & Social-Ecological Impact
Green-Tech process to manufacture IMPCT protein, the first Spirulina-based vegan protein
Superior quality validated on human cells at comptetive price
Carbon Biotech holds a unique intellectual property with a patented process enabling the exclusive cultivation of Spirulina using atmospheric CO2
Through our groundbreaking technology, we where able to reduce the production costs by more then 70 %
Our work is impact-oriented on each level of sustainability: environmentally, socially as well as economically.
Who We Are
Carbon Biotech, an innovative spin-off from Brandenburg University of Technology, is at the forefront of transforming Spirulina, offering Impct Protein as a game-changing solution in sustainable farming and healthy nutrition.
Carbon Biotech strives to positively impact human and planetary health by providing The world’s first alternative protein that is complete
What Drives Us
The rising global demand for animal protein, driven by population growth and the evolving diets of an expanding middle class, is clashing with the limits of sustainability. Climate change compounds this challenge by threatening food and water security worldwide, making it clear that traditional animal agriculture cannot alone meet future food needs.
What We Are Doing
Based on extensive research we will be able to introduce a revolutionary way of producing a novel protein source based on the microalgae Spirulina whilst actively removing CO₂ from the atmosphere.
By achieving this we will be able to tap into the rapidly growing alternative protein market which targets the markets of meat, dairy and egg protein calculated a trillion in 2025.
Copyright 2019 Carbon Biotech
All Rights Reserved.
Website by Mayune.
Prof. Dr. rer. nat. habil. Jan-Heiner Küpper
Carbon Biotech Social Enterprise Stiftungs AG
Altebuchwalder Straße 9
01968 Senftenberg, Kleinkoschen
Registernummer: HAN 13414
T +49 (0) 3573 85 930
F +49 (0) 3573 85 809